A greater drop in CGM mean glucose was observed with combination cagrilintide and semaglutide compared with semaglutide (mean change, 63.9 mg/dL vs
Journal of Composites Science
While both can affect hormone levels and performance, they differ significantly in structure, mechanism and regulation
It is not intended for human or animal consumption, and is not for diagnostic, therapeutic, cosmetic, or medical use
Understanding these distinctions prevents disappointment and helps in deciding whether the peptide suits your particular situation
13 Further research is needed to investigate the interconnected pathophysiologic roles of glucagon, GLP-1, and GIP while determining the niche for twincretin therapy in T2DM